Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - BioXcel Therapeutics, Inc. | tm219787d1_8k.htm |
Exhibit 16.1
March 15, 2021
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have been furnished with a copy of the response to Item 4.01 of Form 8-K for the event that occurred on March 15, 2021, to be filed by our former client, BioXcel Therapeutics, Inc. We agree with the statements made in response to that Item insofar as they relate to our Firm.
Very truly yours,
/s/ BDO USA, LLP